Biodexa Pharmaceuticals BDRX Income Statement (2013-2026)

NASDAQ BDRX
$0.42 +0.03 (+8.98%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Biodexa Pharmaceuticals Quarterly Income Statement

Periods 24 quarters
Latest Jun 2026

Biodexa Pharmaceuticals income statement data for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2013 Dec2014 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Revenue & cost
Revenue
-1.57M0.59M
Cost of RevenueCost of Rev
1.60M1.71M12.1010.03
Gross Profit
1.62M2.440.90
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
-1.26M-0.01M-1.30M
Research & DevelopmentR&D
-12.04M-10.08M-8.01M-2.83M5.63M
Other Operating ExpensesOther Opex
-6.17M-1.16M-5.65M-4.94M-6.54M-2.17M-2.87M-2.61M-3.17M-3.16M-2.33M
Operating ExpensesOpex
-1.26M-0.01M-13.34M-10.08M-8.01M-2.83M5.63M
Operating IncomeOp. Inc
2.89M-15.20M-14.55M-30.42M-4.43M-5.31M
EBIT
2.89M-15.20M-14.55M-30.42M-4.43M-5.31M
Non-operating items
Non Operating Interest Expenses
-0.76M-0.12M-0.57M-0.03M0.06M
Goodwill impairment chargesGoodwill Impair.
-1.86M-1.93M-16.33M
Non Operating Investment IncomeNon-Op. Investment Inc.
-1.75M-1.87M-1.81M
Interest & Investment IncomeInt & Inv Inc
0.47M
Net income details
EBT
2.89M-15.96M-14.04M-30.99M-3.99M-4.83M
Tax ProvisionsTaxes
2.53M1.69M0.40M-0.72M
Profit After TaxPAT
0.36M-15.96M-14.04M-32.68M-4.38M-4.10M
Income from Continuing OperationsIncome (Continuing)
0.36M-13.34M-11.75M-29.30M-4.38M-4.10M
Income from Discontinued OperationsIncome (Discontinued)
-6.00M-1.22M
Consolidated Net IncomeConsol Net Inc.
0.36M-19.34M-12.97M-29.30M-4.38M-4.10M
Income towards Parent CompanyParent Net Inc
0.36M-19.34M-12.97M-29.30M-3.59M-4.46M-4.25M-5.06M
Net Income towards Common StockholdersNet Income
0.36M-19.34M-12.97M-29.30M-3.59M-4.46M-4.25M-5.06M
Additional items
EPS (Basic)
0.10M-5.36M-1.41M-6.84M-0.36M-0.45M-428.63-511.09
Shares Outstanding
3.613.613.613.613.613.619.179.174.284.288.058.059.889.889.889.880.01M0.01M0.01M0.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
4.009.0032.0049.0011.000.00M0.01M0.45M
Interest ExpensesInt Expense
-0.76M-0.12M-0.57M-0.03M0.06M
Tax Rate
87.55%

Biodexa Pharmaceuticals Income Statement API

Pull Biodexa Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BDRX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY